<?xml version="1.0" encoding="UTF-8"?>
<p id="para0005">There are serious gaps in response to the disease even in highly developed economies and healthcare systems. In the UK for example, it appeared to take modeling data from Ferguson's group 
 <xref rid="bib0007" ref-type="bibr">[7]</xref> to persuade the government and its advisors to move rapidly from a “herd immunity” stance to a national lockdown strategy. The delay in China's reporting early cases did not help 
 <xref rid="bib0008" ref-type="bibr">[8]</xref>. Nor has the now revealed under-reporting to international public health authorities of mortality in China – at least 50% higher than initially reported 
 <xref rid="bib0009" ref-type="bibr">[9]</xref>. “Fake news” has also complicated public responses to COVID-19 in many countries. This ranges from considering the virus the result of bioterrorism, to a disease caused by 5G wireless masts. Fake medicines are also a concern, with (typically internet) vendors exploiting fears and concerns by falsely claiming that their products can treat or prevent COVID-19 
 <xref rid="bib0010" ref-type="bibr">[10]</xref>.
</p>
